Lexeo Therapeutics · 19 hours ago
Patient Engagement Manager (Part-time)
New York, NY
Full-time, Part-time
Hybrid
Mid, Senior Level
3+ years expLexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. The Patient Engagement Manager will contribute to incorporating the patient voice into program development and initiatives, acting as a liaison among patients, families, and the community while supporting the company's role in rare disease communities.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Contribute to the development of and manage execution of the medical affairs patient engagement plan aligned with program goals and key deliverables
Maintain and cultivate trust-based relationships with patient advocacy organizations, consistent with the phase of development of Lexeo clinical programs, to enable collaboration across shared goals
Liaise with external agencies to ensure program execution and delivery including content development to support department strategies
Provide internal stakeholders with actionable insights gathered from interactions with patient advocacy groups
Collaborate with Clinical Development and Clinical Operations to support development of asset-specific pre-launch readiness patient materials needed to optimize launch execution
Implement patient engagement programs that include educational programs, patient speaker engagement, advisory councils, and clinical trial awareness
Support congress planning and logistics including identifying opportunities for onsite engagement, booth presence and materials creation
Manage social media channel development and creation of digital assets to support it
Works to amplify the culture of Lexeo as a trusted partner to patients
Represent Lexeo at patient community meetings and events where appropriate
Ensure all Lexeo employees have an opportunity to learn about patient perspective and Lexeo’s commitment to the communities we serve
Adhere to Lexeo Therapeutics’ values, culture, and policies
Qualification
Required
RN, NP, PA, PharmD or other healthcare-associated roles in life sciences with experience working directly with patients and/or patient communities; rare disease, cardiac and/or gene therapy experience preferred
Minimum 3 years of relevant experience at manager-level responsibilities
Interest and capacity to learn and understand program science. Gene therapy experience and/or cardiac disease experience highly desirable
Ability to interpret key scientific data and translate findings into patient-friendly language to meet educational and research needs
Strong interpersonal, presentation, and communication skills, and demonstrated ability to work collaboratively in a dynamic, fast-paced, team-oriented environment and to prioritize activities based on quickly changing information
Excellent project management skills with the ability to manage multiple projects and teams with shifting timelines
Ability to travel approximately 30% within the US and globally, including quarterly to NY HQ
Ability to work Eastern time zone
Ability to work up to 25 hours per week, with the possibility of increased hours as needed
Preferred
Rare disease, cardiac and/or gene therapy experience preferred
Strong PowerPoint presentation and design skills preferred
Company
Lexeo Therapeutics
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
11-50 employees
H1B Sponsorship
Lexeo Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2022 (2)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$514MKey Investors
Balyasny Asset ManagementSarepta Therapeutics
2025-10-16Post Ipo Equity· $154M
2025-05-27Post Ipo Equity· $80M
2024-03-11Post Ipo Equity· $95M
Leadership Team
R. Nolan Townsend
Chief Executive Officer
Louis Tamayo
Chief Financial Officer
Recent News
BioWorld Financial Watch
2026-01-16
2026-01-13
Company data provided by crunchbase